The Anticancer Effect of Metformin Combined with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients with or Without Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis

INTRODUCTION: Despite the growing evidence for the anticancer effect of metformin or its combination with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), the efficacies and side effects of such strategies in non-small cell lung cancer (NSCLC) patients with or without type 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiman, Zheng, Jin, Wang, Wen, Cornett, Elyse M., Kaye, Alan David, Urits, Ivan, Viswanath, Omar, Wei, Fei-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681948/
https://www.ncbi.nlm.nih.gov/pubmed/36282467
http://dx.doi.org/10.1007/s40487-022-00209-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681948/
https://www.ncbi.nlm.nih.gov/pubmed/36282467
http://dx.doi.org/10.1007/s40487-022-00209-0

Ejemplares similares